Laboratory Corporation of America Holdings
Biomarkers and methods for assessing response to inflammatory disease therapy

Last updated:

Abstract:

Provided herein are methods for assessing response to inflammatory disease therapy. The methods include performing immunoassays to generate scores based on quantitative data for expression of biomarkers relating to inflammatory biomarkers to assess disease activity in inflammatory diseases, e.g., rheumatoid arthritis. Also provided are uses of inflammatory biomarkers for guiding treatment decisions.

Status:
Grant
Type:

Utility

Filling date:

18 Oct 2018

Issue date:

2 Aug 2022